Company Profile
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems. Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
Cooperator
Development History
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year.
Awards and Honors
2017: Awarded the "First Batch of Dongwu Science and Technology Entrepreneurship Leaders" title.
2018: Recognized as part of the "Gusu Science and Technology Entrepreneurship Angel Program"; certified as a "National Technology-Based Small and Medium-Sized Enterprise"; became a "Member of the National Health Industry Enterprise Management Association".
2019: Received the "Excellence Award (IVD Category)" at the Weihai Rehearsal of the China Medical Device Innovation and Entrepreneurship Competition.
2020: In 2020, GenDx Biotech won the Silver Medal Presentation Award at the Third China Precision Medicine Conference.
2021: Granted the "High-Tech Enterprise" certificate; company founder Mr. Yu Jibin named "First Batch of Gusu Leading Talents in Innovation and Entrepreneurship"; obtained the "Biosafety Laboratory" registration certificate.
2022: Certified with "ISO 13485 & ISO 19001 Management System" by TÜV SÜD; approved as a "United Nations Unified Procurement Market Entity"; selected as a "Jiangsu Private Science and Technology Enterprise".
2024: Listed in the "Jiangsu Province Key New Technologies and Products Promotion Catalog (2024)".
